Assignee
SALIX PHARMACEUTICALS LTD
US·19 granted patents·20 pending applications·191 citations·filing 2004–2023
Top patents by PatentIndex Score
39 records- 0197US9629828B2Methods of treating traveler's diarrhea and hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2015·Granted Apr 25, 2017·16 cites·12 claims
- 0297US7928115B2Methods of treating travelers diarrhea and hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2010·Granted Apr 19, 2011·32 cites·15 claims
- 0396US9949958B2Methods of treating hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2017·Granted Apr 24, 2018·16 cites·17 claims
- 0494US9629829B2Methods of treating hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2015·Granted Apr 25, 2017·11 cites·27 claims
- 0594US8642573B2Methods of treating hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2013·Granted Feb 4, 2014·24 cites·8 claims
- 0693US10335397B2Methods of treating hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2018·Granted Jul 2, 2019·8 cites·13 claims
- 0793US9421195B2Methods of treating hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2013·Granted Aug 23, 2016·19 cites·12 claims
- 0892US10314828B2Methods of treating hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2017·Granted Jun 11, 2019·10 cites·10 claims
- 0992US9855254B2Methods of treating hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2016·Granted Jan 2, 2018·10 cites·13 claims
- 1088US9273066B2Forms of rifaximin and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2013·Granted Mar 1, 2016·7 cites·20 claims
- 1188US7718197B2Colonic purgative composition with soluble binding agentSALIX PHARMACEUTICALS LTD·Filed 2008·Granted May 18, 2010·9 cites·38 claims
- 1287US7625884B2Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivativesSALIX PHARMACEUTICALS LTD·Filed 2007·Granted Dec 1, 2009·7 cites·9 claims
- 1387US2023330071A1Methods of treating hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 1486US2024066010A1Methods of treating hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 1584US9364467B2Rifaximin derivative and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2015·Granted Jun 14, 2016·4 cites·8 claims
- 1682US9931325B2Methods for treating irritable bowel syndrome (IBS)SALIX PHARMACEUTICALS LTD·Filed 2017·Granted Apr 3, 2018·2 cites·9 claims
- 1782US7687075B2Colonic purgative composition with soluble binding agentSALIX PHARMACEUTICALS LTD·Filed 2004·Granted Mar 30, 2010·15 cites·48 claims
- 1872US9035046B2Rifaximin derivative and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2014·Granted May 19, 2015·1 cites·3 claims
- 1971US2010204173A1Methods of treating hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2009·Application pending·0 cites
- 2068US2010087401A1Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivativesSALIX PHARMACEUTICALS LTD·Filed 2009·Application pending·0 cites
- 2167US2020061032A1Methods of treating hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 2265US9937190B2Use of aminosalicylates in diarrhoea-predominent irritable bowel syndromeSALIX PHARMACEUTICALS LTD·Filed 2014·Granted Apr 10, 2018·0 cites·10 claims
- 2363US2010317681A1Modulation of systemic exposure to rifaximinSALIX PHARMACEUTICALS LTD·Filed 2009·Application pending·0 cites
- 2462US9700545B2Forms of rifaximin and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2016·Granted Jul 11, 2017·0 cites·5 claims
- 2561US2011243879A1Methods of treating hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2011·Application pending·0 cites
- 2660US9546183B2Forms of rifaximin and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2016·Granted Jan 17, 2017·0 cites·4 claims
- 2760US2009324736A1Methods of treating bowel diseases by administering a bowel cleanser and an antibioticSALIX PHARMACEUTICALS LTD·Filed 2009·Application pending·0 cites
- 2856US2011071103A1Methods of treating hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2010·Application pending·0 cites
- 2956US2011065741A1Methods for treating irritable bowel syndrome (ibs)SALIX PHARMACEUTICALS LTD·Filed 2010·Application pending·0 cites
- 3055US2017333562A1Formulations of rifaximin and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 3154US2011035232A1Methods of treating hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2010·Application pending·0 cites
- 3254US2011105550A1Forms of rifaximin and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2010·Application pending·0 cites
- 3352US2020069664A1Methods for treating infectionSALIX PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 3452US2019231771A1Methods for treatment and prevention of opioid induced constipation using oral compositions of methylnaltrexoneSALIX PHARMACEUTICALS LTD·Filed 2018·Application pending·0 cites
- 3544US2011055943A1Novel therapeutic targets in inflammatory bowel diseaseSALIX PHARMACEUTICALS LTD·Filed 2008·Application pending·0 cites
- 3642US2017087134A1Formulations of rifaximin and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2016·Application pending·0 cites
- 3735US2015164866A1Methods of administering rifaximin for weight loss and treatment of obesitySALIX PHARMACEUTICALS LTD·Filed 2015·Application pending·0 cites
- 3835US2015164867A1Methods of improving long-term survival and reducing hospitalization readmission rates for subjects suffering from hepatic encephalopathySALIX PHARMACEUTICALS LTD·Filed 2015·Application pending·0 cites
- 3925US2016128990A1Methods of using rifaximin in position emission tomography (pet) scansSALIX PHARMACEUTICALS LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SALIX PHARMACEUTICALS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →